{{Rsnum
|rsid=6504074
|Gene=BRIP1
|Chromosome=17
|position=61822429
|Orientation=plus
|GMAF=0.3343
|Gene_s=BRIP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 58.9 | 36.6 | 4.5
| HCB | 65.0 | 31.4 | 3.6
| JPT | 57.5 | 36.3 | 6.2
| YRI | 19.0 | 51.7 | 29.3
| ASW | 26.3 | 49.1 | 24.6
| CHB | 65.0 | 31.4 | 3.6
| CHD | 58.3 | 38.9 | 2.8
| GIH | 17.8 | 52.5 | 29.7
| LWK | 16.4 | 51.8 | 31.8
| MEX | 32.8 | 44.8 | 22.4
| MKK | 19.2 | 53.8 | 26.9
| TSI | 63.7 | 25.5 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23473757
|Title=BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer
}}

{{PMID Auto
|PMID=17342202
|Title=Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
|OA=1
}}

{{PMID Auto
|PMID=19127258
|Title=A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.
|OA=1
}}

{{PMID Auto
|PMID=24301948
|Title=Further evidence for the contribution of the BRCA1-interacting protein-terminal helicase 1 (BRIP1) gene in breast cancer susceptibility
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}